# active_site_0017

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **D** — Position 146 (Proton acceptor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MTRKSILVTGASSGLGYAAVQKLAENGFYVFAAVREIRGMFSNIKNIKELKLDLANEQSIEELFIYIEATQKDYPLWGLVNNAGICVPSPLELLREFDLRQQLDTNVIGQLLVTQFALPFIRKSKGRIINITSGLGSIAVPYLGAYSIAQFAKMAFTDVLRRELKHSGVTVSVVQPGAIYTPIWDKFLVTGQEILDNSLDEKRKIYERSFIEFLKASQIGVNSVKTTRNDFAKVILDIFKAEIPETHYYVGDDAKNFSNKSKILTVTEIDEWFDLQSPTESEFKKI

[Multiple Choices]
A. Position 159 (Proton donor)
B. Position 250 (Proton acceptor)
C. Position 735 (For beta-ketoacyl synthase activity)
D. Position 146 (Proton acceptor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence exactly matches the UniProt entry, which annotates residue 146 as a proton acceptor. The annotation is transferred by similarity from UniProtKB:P00334, so it supports the key as a database-based inference, not as direct experimental confirmation for this protein.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Choice C is inconsistent with the 286-residue sequence, but the supplied sequence and choices do not provide a defensible way to distinguish the exact catalytic role at position 146 from the other in-range residue claims.


**Missing item-specific fact**

> The protein-specific active-site annotation assigning position 146 as a proton acceptor, or equivalent structural or experimental evidence.


**Reason**

> Identifying the keyed residue and role depends on an external annotation or protein-specific evidence absent from the input; recognizing the sequence or invoking a predictor would not make that information supplied.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer-only annotation supports D; the other in-range options are not supported by the supplied evidence. Choice C is outside the sequence length.


### Important caveats

- The active-site assignment is similarity-transferred from P00334 (ECO:0000250), rather than shown here to be experimentally established for this exact protein.
- The sequence match and supporting UniProt records were available only to the reviewer, not the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Choice C is inconsistent with the 286-residue sequence, but the supplied sequence and choices do not provide a defensible way to distinguish the exact catalytic role at position 146 from the other in-range residue claims.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific active-site annotation assigning position 146 as a proton acceptor, or equivalent structural or experimental evidence.",
    "reason": "Identifying the keyed residue and role depends on an external annotation or protein-specific evidence absent from the input; recognizing the sequence or invoking a predictor would not make that information supplied."
  },
  "case_id": "active_site_0017",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry, which annotates residue 146 as a proton acceptor. The annotation is transferred by similarity from UniProtKB:P00334, so it supports the key as a database-based inference, not as direct experimental confirmation for this protein."
  },
  "important_caveats": [
    "The active-site assignment is similarity-transferred from P00334 (ECO:0000250), rather than shown here to be experimentally established for this exact protein.",
    "The sequence match and supporting UniProt records were available only to the reviewer, not the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only annotation supports D; the other in-range options are not supported by the supplied evidence. Choice C is outside the sequence length."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0017",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry, which annotates residue 146 as a proton acceptor. The annotation is transferred by similarity from UniProtKB:P00334, so it supports the key as a database-based inference, not as direct experimental confirmation for this protein.",
    "evidence_ids": ["C1", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Choice C is inconsistent with the 286-residue sequence, but the supplied sequence and choices do not provide a defensible way to distinguish the exact catalytic role at position 146 from the other in-range residue claims.",
    "missing_item_specific_fact": "The protein-specific active-site annotation assigning position 146 as a proton acceptor, or equivalent structural or experimental evidence.",
    "reason": "Identifying the keyed residue and role depends on an external annotation or protein-specific evidence absent from the input; recognizing the sequence or invoking a predictor would not make that information supplied."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only annotation supports D; the other in-range options are not supported by the supplied evidence. Choice C is outside the sequence length."
  },
  "important_caveats": [
    "The active-site assignment is similarity-transferred from P00334 (ECO:0000250), rather than shown here to be experimentally established for this exact protein.",
    "The sequence match and supporting UniProt records were available only to the reviewer, not the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A2G0QDN4 (sequence matched, 286 AA) explicitly annotates position 146 as 'Proton acceptor' active site (evidence C5, H3). The evidence code is ECO:0000250 (inferred by similarity from P00334), making this a homology-based computational annotation rather than direct experimental evidence for this specific protein. However, the annotation is consistent with the SDR (short-chain dehydrogenase/reductase) family catalytic mechanism, where a conserved Tyr acts as the proton acceptor. The protein is identified as a 3-amino-tetrahydro-pyrrolizinone reductase (EC 1.1.-.-), an oxidoreductase consistent with SDR catalytic chemistry.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Three of four options can be eliminated by basic reasoning: (1) Position 735 exceeds the 286-residue protein length (arithmetic elimination of C). (2) Position 159 is Valine (V), which lacks ionizable side-chain groups and cannot function as a proton donor (biochemical elimination of A). (3) Position 250 is also Valine (V), which cannot function as a proton acceptor (biochemical elimination of B). Position 146 is Tyrosine (Y), a residue with a phenolic hydroxyl group capable of proton transfer, consistent with the SDR catalytic tetrad (Ser-Tyr-Lys-Asn) mechanism. The N-terminal Rossmann motif (TGASSG, positions 8-13) and the 'NITSGLGS' region around positions 130-137 identify this as an SDR-family enzyme, in which the catalytic Tyr is the proton acceptor.


**Missing item-specific fact**

> None required for elimination-based reasoning. Precise identification of position 146 over position 142 (also Tyr) would benefit from structural knowledge of SDR active-site geometry, but the elimination of all other options by amino-acid chemistry and sequence length makes the answer determinable without that detail.


**Reason**

> The question is answerable through general biological reasoning: amino-acid chemistry (Valine cannot donate/accept protons), arithmetic (position 735 > 286), and recognition of SDR-family motifs in the sequence. No item-specific database lookup is strictly necessary to arrive at the correct answer, though the positive identification of Tyr-146 as the catalytic residue is strengthened by SDR-family knowledge.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and C are clearly eliminable: C exceeds protein length; A and B name Valine residues as proton donors/acceptors, which is biochemically implausible. Only option D names a chemically plausible catalytic residue (Tyr) at a valid position. No ambiguity in the final answer.


### Important caveats

- The active-site annotation at position 146 carries evidence code ECO:0000250 (inferred by similarity from P00334), meaning it is a computational/homology transfer rather than direct experimental characterization of this specific enzyme.
- The protein is only 286 residues; the annotation source (P00334) is a different protein, and the exact active-site geometry was not experimentally verified for this Xenorhabdus hominickii enzyme.
- Position 142 is also a Tyrosine in the same region; distinguishing 146 from 142 purely from sequence requires structural or detailed family-level knowledge, though this does not affect the answer since all other options are eliminated by more basic reasoning.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Three of four options can be eliminated by basic reasoning: (1) Position 735 exceeds the 286-residue protein length (arithmetic elimination of C). (2) Position 159 is Valine (V), which lacks ionizable side-chain groups and cannot function as a proton donor (biochemical elimination of A). (3) Position 250 is also Valine (V), which cannot function as a proton acceptor (biochemical elimination of B). Position 146 is Tyrosine (Y), a residue with a phenolic hydroxyl group capable of proton transfer, consistent with the SDR catalytic tetrad (Ser-Tyr-Lys-Asn) mechanism. The N-terminal Rossmann motif (TGASSG, positions 8-13) and the 'NITSGLGS' region around positions 130-137 identify this as an SDR-family enzyme, in which the catalytic Tyr is the proton acceptor.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None required for elimination-based reasoning. Precise identification of position 146 over position 142 (also Tyr) would benefit from structural knowledge of SDR active-site geometry, but the elimination of all other options by amino-acid chemistry and sequence length makes the answer determinable without that detail.",
    "reason": "The question is answerable through general biological reasoning: amino-acid chemistry (Valine cannot donate/accept protons), arithmetic (position 735 > 286), and recognition of SDR-family motifs in the sequence. No item-specific database lookup is strictly necessary to arrive at the correct answer, though the positive identification of Tyr-146 as the catalytic residue is strengthened by SDR-family knowledge."
  },
  "case_id": "active_site_0017",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A2G0QDN4 (sequence matched, 286 AA) explicitly annotates position 146 as 'Proton acceptor' active site (evidence C5, H3). The evidence code is ECO:0000250 (inferred by similarity from P00334), making this a homology-based computational annotation rather than direct experimental evidence for this specific protein. However, the annotation is consistent with the SDR (short-chain dehydrogenase/reductase) family catalytic mechanism, where a conserved Tyr acts as the proton acceptor. The protein is identified as a 3-amino-tetrahydro-pyrrolizinone reductase (EC 1.1.-.-), an oxidoreductase consistent with SDR catalytic chemistry."
  },
  "important_caveats": [
    "The active-site annotation at position 146 carries evidence code ECO:0000250 (inferred by similarity from P00334), meaning it is a computational/homology transfer rather than direct experimental characterization of this specific enzyme.",
    "The protein is only 286 residues; the annotation source (P00334) is a different protein, and the exact active-site geometry was not experimentally verified for this Xenorhabdus hominickii enzyme.",
    "Position 142 is also a Tyrosine in the same region; distinguishing 146 from 142 purely from sequence requires structural or detailed family-level knowledge, though this does not affect the answer since all other options are eliminated by more basic reasoning."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly eliminable: C exceeds protein length; A and B name Valine residues as proton donors/acceptors, which is biochemically implausible. Only option D names a chemically plausible catalytic residue (Tyr) at a valid position. No ambiguity in the final answer."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0017",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A2G0QDN4 (sequence matched, 286 AA) explicitly annotates position 146 as 'Proton acceptor' active site (evidence C5, H3). The evidence code is ECO:0000250 (inferred by similarity from P00334), making this a homology-based computational annotation rather than direct experimental evidence for this specific protein. However, the annotation is consistent with the SDR (short-chain dehydrogenase/reductase) family catalytic mechanism, where a conserved Tyr acts as the proton acceptor. The protein is identified as a 3-amino-tetrahydro-pyrrolizinone reductase (EC 1.1.-.-), an oxidoreductase consistent with SDR catalytic chemistry.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Three of four options can be eliminated by basic reasoning: (1) Position 735 exceeds the 286-residue protein length (arithmetic elimination of C). (2) Position 159 is Valine (V), which lacks ionizable side-chain groups and cannot function as a proton donor (biochemical elimination of A). (3) Position 250 is also Valine (V), which cannot function as a proton acceptor (biochemical elimination of B). Position 146 is Tyrosine (Y), a residue with a phenolic hydroxyl group capable of proton transfer, consistent with the SDR catalytic tetrad (Ser-Tyr-Lys-Asn) mechanism. The N-terminal Rossmann motif (TGASSG, positions 8-13) and the 'NITSGLGS' region around positions 130-137 identify this as an SDR-family enzyme, in which the catalytic Tyr is the proton acceptor.",
    "missing_item_specific_fact": "None required for elimination-based reasoning. Precise identification of position 146 over position 142 (also Tyr) would benefit from structural knowledge of SDR active-site geometry, but the elimination of all other options by amino-acid chemistry and sequence length makes the answer determinable without that detail.",
    "reason": "The question is answerable through general biological reasoning: amino-acid chemistry (Valine cannot donate/accept protons), arithmetic (position 735 > 286), and recognition of SDR-family motifs in the sequence. No item-specific database lookup is strictly necessary to arrive at the correct answer, though the positive identification of Tyr-146 as the catalytic residue is strengthened by SDR-family knowledge."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and C are clearly eliminable: C exceeds protein length; A and B name Valine residues as proton donors/acceptors, which is biochemically implausible. Only option D names a chemically plausible catalytic residue (Tyr) at a valid position. No ambiguity in the final answer."
  },
  "important_caveats": [
    "The active-site annotation at position 146 carries evidence code ECO:0000250 (inferred by similarity from P00334), meaning it is a computational/homology transfer rather than direct experimental characterization of this specific enzyme.",
    "The protein is only 286 residues; the annotation source (P00334) is a different protein, and the exact active-site geometry was not experimentally verified for this Xenorhabdus hominickii enzyme.",
    "Position 142 is also a Tyrosine in the same region; distinguishing 146 from 142 purely from sequence requires structural or detailed family-level knowledge, though this does not affect the answer since all other options are eliminated by more basic reasoning."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A2G0QDN4` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 28. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2G0QDN4.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:47.620054+00:00.  

```json
"A0A2G0QDN4"
```

Source SHA-256: `5510f043b076696b57f87efa7739b48cfedb1b8f19f87a14fd6d5a4d3624e099`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2G0QDN4.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:47.620054+00:00.  

```json
{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39428351","source":"PubMed"}],"value":"1.1.-.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305","id":"39428351","source":"PubMed"}],"value":"3-amino-tetrahydro-pyrrolizinone reductase"}}}
```

Source SHA-256: `5510f043b076696b57f87efa7739b48cfedb1b8f19f87a14fd6d5a4d3624e099`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2G0QDN4.json)  
**Locator:** `/features/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:47.620054+00:00.  

```json
{"description":"Proton acceptor","evidences":[{"evidenceCode":"ECO:0000250","id":"P00334","source":"UniProtKB"}],"location":{"end":{"modifier":"EXACT","value":146},"start":{"modifier":"EXACT","value":146}},"type":"Active site"}
```

Source SHA-256: `5510f043b076696b57f87efa7739b48cfedb1b8f19f87a14fd6d5a4d3624e099`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2G0QDN4.json)  
**Locator:** `/references/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:47.620054+00:00.  

```json
{"citation":{"authors":["Effert J.","Westphalen M.","Calderari A.","Shi Y.M.","Elamri I.","Najah S.","Gruen P.","Li Y.","Gruez A.","Weissman K.J.","Bode H.B."],"citationCrossReferences":[{"database":"PubMed","id":"39428351"},{"database":"DOI","id":"10.1002/anie.202411258"}],"citationType":"journal article","firstPage":"e202411258","id":"39428351","journal":"Angew. Chem. Int. Ed.","lastPage":"e202411258","publicationDate":"2024","title":"Pyrrolizwilline, a unique bacterial alkaloid assembled by a nonribosomal peptide synthetase and non-enzymatic dimerization.","volume":"63"},"referenceComments":[{"type":"STRAIN","value":"DSM 17903 / CIP 109072 / KE01"}],"referenceNumber":2,"referencePositions":["FUNCTION","CATALYTIC ACTIVITY"]}
```

Source SHA-256: `5510f043b076696b57f87efa7739b48cfedb1b8f19f87a14fd6d5a4d3624e099`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A2G0QDN4?format=txt&versions=28)  
**Locator:** `lines 73-75`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 28 / 1.  
**Retrieved:** 2026-11-02T04:24:49.959850+00:00.  

```text
FT   ACT_SITE        146
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P00334"
```

Source SHA-256: `e9a43167d987f4d30c210cf3857bc305e9fa0ec071e154f20f0d529315825c29`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 17. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
